4//SEC Filing
GARCEAU ROGER 4
Accession 0001213900-25-054283
CIK 0001359931other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:05 PM ET
Size
5.8 KB
Accession
0001213900-25-054283
Insider Transaction Report
Form 4
GARCEAU ROGER
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-12+24,000→ 24,000 totalExercise: $3.26From: 2026-06-12Exp: 2035-06-11→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001451767
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:05 PM ET
- Size
- 5.8 KB